HERO-2
- 17,091 participants
- 12 sites in New Zealand
- 11 sites in India
- 3 sites in Hong Kong
- 3 sites in Malaysia
- 3 sites in Philippines
- 1 site in Thailand
- 539 sites in 47 countries
Hirulog Early Reperfusion/Occlusion. An open prospectively randomised comparison of Hirulog versus Heparin in patients receiving Aspirin and thrombolysis (Streptokinase) for the treatment of acute myocardial infarction. 17,091 patients at 539 sites in 47 countries.